Transplantation · 1997 · 41 citations · 6 references
MedicineInfectious DiseasesSurgeryHepatologyTransplant ImmunologyTransplant SurgeryGraft RejectionHepatobiliary DiseaseLiver DiseaseLiver TransplantationLiving Donor TransplantationTransplant RejectionDeceased Donor Liver TransplantationDisease TransmissionInfection After TransplantationInfection Transmission RiskInfections After TransplantationLiver Transplant RejectionLiver Transplantation ManagementTransplant-associated Infections
Exclusion of occult diseases in the donor organ and prevention of infectious disease transmission are minimal requirements in organ transplantation. We report here a case of hepatic graft tuberculosis, which was most likely transmitted by the graft from the living-related donor. The course of the recipient included tuberculosis, rejection, and other infections, which led to vanishing bile duct syndrome. Due to various infections and tuberculosis, as well as a strong interaction between rifampicin and tacrolimus, the patient died of pneumonia on day 273 after transplantation. This case emphasizes the importance of care in the selection of a living-related donor for liver transplantation.
6
Rifampicin reduces effectiveness and bioavailability of prednisolone.
W A McAllister, Philip J. Thompson, Sayed M.H. Al-Habet et al. · BMJ · 1983 · 228 citations · Full text
TUBERCULOSIS IN LIVER TRANSPLANT PATIENTS
Burt R. Meyers, Michele Halpern, Patricia A. Sheiner et al. · Transplantation · 1994 · 93 citations
FK506 CONVERSION THERAPY IN PEDIATRIC LIVER TRANSPLANTATION
Hiroto Egawa, Carlos O. Esquivel, Samuel So et al. · Transplantation · 1994 · 34 citations
Medicine, Immunology, Surgery +14